WALTHAM, Mass.--(BUSINESS WIRE)--Sept. 21, 2006--NeuroMetrix, Inc. (NASDAQ: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, announced today that it is scheduled to present at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York City at 12:00pm (EST) on Tuesday, September 26, 2006. The audio presentation will be simultaneously available via webcast on the "Investors" home page at http://www.neurometrix.com.
